Purnartha PMS

PMS Rating

IME PMS Rating

3 of 5 stars

Not a top recommendation as it is still a young AMC at this time : Started in 2011 as a RIA, Purnartha has established their research credentials and stock selection. While it is still early days in the PMS and AIF offerings (launched in 2020), we are positive on the AMC & teams pedigree, and the ability of their research to identify quality ideas. A higher than normal level of concentration makes this more suitable for higher-risk investors.

The PMS/AIF AMC Rating is derived on the basis of our analysis on 5 key qualitative parameters that we use to analyse the quality of a PMS/AIF Provider. These include an assessment of the size of the AMC, the pedigree of the AMC, the pedigree of the team, the value of the investment philosophy & the level of differentiation. These insights of our central research team are documented in the IME RMS, and can be accessed during a consultation call with an IME PMS specialist.

PMS Background

Discretionary AUM (1419cr) | Promoter Category ()

Investment Philosophy


Purnartha considers the following aspects in creating a portfolio

  • Market-sector agnostic: From the universe of Nifty-500, the team selects their best ideas and remains agnostic to sector weights
  • Fundamental Driven: Invest in fundamentally sound businesses and demonstrate growth potential

Characteristics of companies Purnartha likes to Invest in

  • No or Low Leverage: Growth driven by not relying on borrowings (ex BFSI), which indicates enough capital generated internally
  • Growth: Focus on volume growth and structural drivers that drive the same
  • Management Pedigree: Assess the alignment of interests of the management with minority shareholders
  • Company Culture: Conduct channel checks to gain insights

Inv Team

Investment Team

Rohit Jain | 3-star rated FM

Fund Manager | 16 yrs Experience | 3 yrs at current firm

Past Experience: Lead analyst(Crisil Global)

Fund Manager Profile: Rohit is a Chartered Accountant and holds a Post-graduate diploma in Business Management. He has worked with CRISIL (an S&P Global Company) and Systematix Shares among others and carries over 13 years of experience in Equity Research for Institutional investors. Over the years, he has built extensive knowledge in financial modeling and valuations with sector expertise across major industries. Rohit also keeps himself updated on the latest developments on taxation, auditing, and compliance, which only adds to his existing wealth management and market know-how.

PMS/AIF Schemes

PMS & Listed Equity AIF Schemes

Returns as of 28-Feb-24.

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.